Philip Morris International (NYSE:PM) Updates Q3 2026 Earnings Guidance

Philip Morris International (NYSE:PM) issued an update on its third quarter 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 2.290-2.340 for the period, compared to the consensus EPS estimate of 2.250. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

PM has been the subject of a number of research analyst reports. BTIG Research set a $221.00 price objective on shares of Philip Morris International and gave the stock a “buy” rating in a research report on Friday, July 24th. UBS Group upped their price target on shares of Philip Morris International from $168.00 to $182.00 and gave the stock a “neutral” rating in a report on Thursday, July 2nd. Morgan Stanley raised their price objective on Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Citigroup boosted their price objective on Philip Morris International from $210.00 to $225.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Finally, Bank of America reaffirmed a “buy” rating on shares of Philip Morris International in a report on Thursday, May 21st. Ten equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Philip Morris International currently has a consensus rating of “Moderate Buy” and an average target price of $205.89.

Philip Morris International Stock Performance

Shares of NYSE:PM opened at $185.71 on Thursday. Philip Morris International has a 52 week low of $142.11 and a 52 week high of $207.76. The firm has a market cap of $289.45 billion, a PE ratio of 26.68, a price-to-earnings-growth ratio of 2.37 and a beta of 0.37. The firm’s fifty day moving average is $188.25 and its 200-day moving average is $178.77.

Philip Morris International (NYSE:PM) last announced its earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.05 by $0.15. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.The business had revenue of $11.19 billion during the quarter, compared to analyst estimates of $10.60 billion. During the same period last year, the company earned $1.89 EPS. Philip Morris International’s revenue for the quarter was up 10.4% compared to the same quarter last year. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. Sell-side analysts forecast that Philip Morris International will post 8.39 EPS for the current year.

Trending Headlines about Philip Morris International

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: Higher 2026 earnings outlook: Philip Morris raised its 2026 adjusted diluted EPS forecast to $8.35-$8.50, with the increase attributed to currency tailwinds rather than a change to its underlying operational outlook. The guidance supports investor confidence and is above the company’s previous expectations. Philip Morris Raises 2026 Earnings Guidance Amid Currency Tailwinds
• Positive Sentiment: ZYN portfolio expansion: PMI’s U.S. business is broadening ZYN with new 1.5 mg and 8 mg strengths, the higher-moisture ZYN ULTRA line, additional flavors and formats, and more pouches per can. The expanded range could attract more legal-age adult nicotine consumers and support volume growth. PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices
• Positive Sentiment: Regulatory support for nicotine pouches: FDA authorization for 11 ZYN products, including higher-strength ZYN ULTRA offerings, strengthens PMI’s position in the fast-growing U.S. nicotine-pouch market and provides a foundation for scaling production after substantial manufacturing investments. FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
• Neutral Sentiment: Execution remains important: The ZYN rollout is strategically favorable, but the earnings benefit will depend on consumer adoption, manufacturing capacity and the company’s ability to convert product expansion into sustainable sales and profit growth.

Institutional Trading of Philip Morris International

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Resurgent Financial Advisors LLC lifted its position in shares of Philip Morris International by 3.7% in the 4th quarter. Resurgent Financial Advisors LLC now owns 1,523 shares of the company’s stock worth $244,000 after purchasing an additional 54 shares during the period. Douglass Winthrop Advisors LLC increased its position in shares of Philip Morris International by 0.3% during the fourth quarter. Douglass Winthrop Advisors LLC now owns 18,344 shares of the company’s stock worth $2,942,000 after buying an additional 56 shares during the period. Aristotle Capital Management LLC increased its position in shares of Philip Morris International by 4.4% during the fourth quarter. Aristotle Capital Management LLC now owns 1,384 shares of the company’s stock worth $222,000 after buying an additional 58 shares during the period. Nia Impact Advisors LLC increased its position in shares of Philip Morris International by 4.2% during the second quarter. Nia Impact Advisors LLC now owns 1,577 shares of the company’s stock worth $287,000 after buying an additional 63 shares during the period. Finally, Sand Hill Global Advisors LLC raised its stake in Philip Morris International by 3.5% during the fourth quarter. Sand Hill Global Advisors LLC now owns 1,855 shares of the company’s stock worth $298,000 after buying an additional 63 shares during the last quarter. Institutional investors and hedge funds own 78.63% of the company’s stock.

About Philip Morris International

Philip Morris International Inc is a global tobacco and nicotine company headquartered in Stamford, Connecticut. The company develops, manufactures and markets cigarettes, smoke-free products, nicotine products and related consumer offerings in markets around the world.

Its portfolio includes internationally recognized cigarette brands such as Marlboro, Parliament, L&M and Chesterfield. PMI is also expanding beyond traditional cigarettes through heated-tobacco products, including IQOS, e-vapor products such as VEEV, and oral nicotine products including ZYN, which became part of the company’s portfolio following its acquisition of Swedish Match.

Philip Morris International was established as an independent company in 2008 after being separated from Altria Group, whose U.S.